[2025] Participation in the Korean Dementia Society Fall Academic Conference

Bredis Healthcare participated in the 2025 Fall Conference of the Korean Dementia Society, held on November 1, 2025, at the Swiss Grand Hotel.

At this conference, which marked the first anniversary of Lecanemab (Leqembi)’s introduction in Korea, participants intensively shared their practical clinical experience.

Drawing on field experiences from various medical institutions—including university hospitals, general hospitals, and private clinics—discussions focused on practical challenges arising during the application of anti-amyloid therapies, such as disease classification systems, fee structures, and a lack of coordination between medical institutions. Discussions also continued regarding the establishment of an institutional foundation aligned with the changing paradigm of dementia care.

The event provided an opportunity to hear firsthand feedback from the field following the introduction of the treatment, and it allowed us to reflect once again on the role and potential of Bredis Healthcare in the field of precision bioanalysis.